Taken together, these results demonstrate that TGF-β1 inhibits the growth and development of HCC cells by targeting the Hippo signaling pathway through the regulation of a series of key proteins, especially the nucleocytoplasmic translocation of YAP1. This evidence concerns the gene YAP1 and hepatocellular carcinoma.